Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print May 9, 2005, 10.1110/ps.041312805
Protein Science (2005), 14:1429-1437. Published by Cold Spring Harbor Laboratory Press. Copyright © 2005 The Protein Society
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.041312805v1
14/6/1429    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamniuk, A. P.
Right arrow Articles by Vogel, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamniuk, A. P.
Right arrow Articles by Vogel, H. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Calcium- and magnesium-dependent interactions between calcium- and integrin-binding protein and the integrin {alpha}IIb cytoplasmic domain

Aaron P. Yamniuk and Hans J. Vogel

Structural Biology Research Group, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada T2N 1N4

Reprint requests to: Hans J. Vogel, Structural Biology Research Group, Department of Biological Sciences, University of Calgary, 2500 University Drive NW, Calgary, AB, Canada T2N 1N4; e-mail: vogel{at}ucalgary.ca; fax: (403) 289-9311.

(RECEIVED December 23, 2004; FINAL REVISION February 22, 2005; ACCEPTED March 14, 2005)


    Abstract
 TOP
 Abstract
 Introduction
 Results
 Discussion
 Materials and methods
 References
 
Calcium- and integrin-binding protein (CIB) is a small EF-hand calcium-binding protein that is involved in hemostasis through its interaction with the {alpha}IIb cytoplasmic domain of integrin{alpha}IIb{beta}3. We have previously demonstrated that CIB lacks structural stability in the absence of divalent metal ions but that it acquires a well-folded conformation upon addition of Ca2+ or Mg2+. Here, we have used fluorescence spectroscopy, NMR spectroscopy, and isothermal titration calorimetry to demonstrate that both Ca2+-bound CIB (Ca2+-CIB) and the Mg2+-bound protein (Mg2+-CIB) bind with high affinity and through a similar mechanism to {alpha}IIb cytoplasmic domain peptides, but that metal-free CIB (apo-CIB) binds in a different manner. The interactions are thermodynamically distinct for Ca2+-CIB and Mg2+-CIB, but involve hydrophobic interactions in each case. Since the Mg2+ concentration inside the cell is sufficient to saturate CIB at all times, our results imply that CIB would be capable of binding to the {alpha}IIb cytoplasmic domain independent of an intracellular Ca2+ stimulus in vivo. This raises the question of whether CIB can act as a Ca2+ sensor in {alpha}IIb{beta}3 signaling or if other regulatory mechanisms such as fibrinogen-induced conformational changes in {alpha}IIb{beta}3, post-translational modifications, or the binding of other accessory proteins mediate the interactions between CIB and {alpha}IIb{beta}3. Differences in NMR spectra do suggest, however, that Ca2+-binding to the Mg2+- CIB-{alpha}IIb complex induces subtle structural changes that could further modulate the activity of {alpha}IIb{beta}3.

Keywords: calcium- and integrin-binding protein; calcium; magnesium; integrin; peptide; isothermal titration calorimetry; nuclear magnetic resonance spectroscopy; fluorescence spectroscopy

Abbreviations: CIB, calcium- and integrin-binding protein • Ca2+-CIB, calcium-bound CIB • Mg2+-CIB, magnesium-bound CIB • apo-CIB, metal-free CIB • CaM, calmodulin • CnB, calcineurin B • can, calcineurin A • NCS, neuronal calcium sensor • TnC, troponin C • TnI, troponin I

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.041312805.


    Introduction
 TOP
 Abstract
 Introduction
 Results
 Discussion
 Materials and methods
 References
 
Integrins are a large family of transmembrane glycoproteins that are important in mediating adhesion between cells as well as the attachment of cells to the extracellular matrix. The highly abundant platelet integrin {alpha}IIb{beta}3 links the cytoplasmic and extracellular environments, acting as a bidirectional signaling molecule in the platelet aggregation process leading to blood clot formation (Calvete 2004). Platelet agonists trigger inside-out signaling, where ligand binding to the cytoplasmic domains causes conformational changes that increase the affinity of the extracellular domains for fibrinogen and the von Willebrand factor, initiating platelet aggregation. The subsequent ligand binding by the extracellular domains also triggers outside-in signaling events that increase the avidity of binding and enhance the aggregation process (Calvete 2004; Mould and Humphries 2004; Xiao et al. 2004). Despite their relatively small sizes, the cytoplasmic domains of {alpha}IIb and {beta}3 interact with each other and many intracellular ligands and play an important role in mediating these signaling events (Vinogradova et al. 2002; Weljie et al. 2002).

Calcium- and integrin-binding protein (CIB) is a 22-kDa calcium (Ca2+)-binding protein of the helix-loop-helix EF-hand superfamily. It was originally identified as a specific binding partner for the {alpha}IIb cytoplasmic domain of platelet integrin (Naik et al. 1997), but has since been suggested to bind to several other proteins(Wu and Lieber 1997; Kauselmann et al. 1999; Stabler et al. 1999; Ito et al. 2000; Fang et al. 2001; Haataja et al. 2002; Henderson et al. 2002; Hollenbach et al. 2002; Whitehouse et al. 2002). Both in vivo and in vitro binding studies using intact {alpha}IIb{beta}3 as well as {alpha}IIb cytoplasmic domain peptides have shown that CIB specifically binds to the cytoplasmic domain of {alpha}II band that its affinity is enhanced in the presence of Ca2+ (Shock et al. 1999; Barry et al. 2002; Tsuboi 2002). CIB is also myristoylated on its N terminus (Stabler et al. 1999), although it binds to {alpha}IIb independent of myristoylation (Shock et al. 1999; Tsuboi 2002). The sequence homology of CIB to calmodulin (CaM), calcineurin B (CnB), and members of the neuronal calcium sensor (NCS) family suggests that CIB might function as a Ca2+ sensor in {alpha}IIb{beta}3-mediated inside-out signaling (Hwang and Vogel 2000). Indeed CIB binds two Ca2+ ions with its C-domain EF-hands EF-III and EF-IV with dissociation constants (Kd) near 1.9 µM and 0.5 µM, respectively (Yamniuk et al. 2004). However, there have also been reports of apo-CIB binding to {alpha}IIb (Shock et al. 1999; Vallar et al. 1999; Tsuboi 2002). Moreover, unlike many other Ca2+-regulatory proteins, a single Mg2+ binds to EF-III of CIB (Kd=120 µM) and causes conformational changes similar to those induced by Ca2+ (Yamniuk et al. 2004). The binding of either Ca2+ or Mg2+ to CIB significantly increases the structural stability of the protein in comparison to apo-CIB, which is a molten globule (Yamniuk et al. 2004). Here we have studied the binding of {alpha}IIb cytoplasmic domain peptides to all three forms of CIB, metal-free CIB (apo-CIB), Ca2+-bound CIB (Ca2+-CIB), and Mg2+-bound CIB (Mg2+-CIB). Our results demonstrate that both Ca2+-CIB and Mg2+-CIB bind strongly to the {alpha}IIb cytoplasmic domain in a similar manner, whereas apo-CIB binds differently and with lower affinity. Because the free intracellular Mg2+ concentration in platelets is maintained between 0.5 and 1.3mM (Matsuno et al. 1993), our results suggest that CIB would be capable of binding {alpha}IIb independent of a Ca2+ stimulus in vivo. Therefore, other regulatory mechanisms are likely involved in vivo, in mediating the interactions of CIB with {alpha}IIb.


    Results
 TOP
 Abstract
 Introduction
 Results
 Discussion
 Materials and methods
 References
 
Fluorescence spectroscopy
We first studied the interactions between CIB and the cytoplasmic domain of {alpha}IIb by fluorescence spectroscopy, taking advantage of the single Trp residue in the {alpha}IIb cytoplasmic domain (W988). Studying peptide binding directly in this fashion is possible here because CIB does not contain any Trp residues in its sequence. Titrations were performed to establish the stoichiometry and affinity of binding, while steady state fluorescence emission spectra and quenching studies were used to determine the environment of W988 in each complex. Studies were performed using a "long" peptide ({alpha}IIb-L) encompassing the entire cytoplasmic domain or a "short" peptide ({alpha}IIb-S) encompassing only the membrane proximal region. To test the role of ionic interactions all experiments were performed in the presence and absence of 100 mM KCl. NMR studies indicate that the conformation of CIB is unchanged between 0 and 100 mM KCl and therefore any salt-dependent binding effects are unlikely to be caused by structural modifications (data not shown).

The steady state fluorescence emission spectrum of free {alpha}IIb-L is characteristic of a solvent-exposed Trp having an emission wavelength maximum near 355 nm (Fig. 1AGo). Addition of Ca2+-CIB increased the steady state emission intensity up to a stoichiometry of 1:1 with a Kd near 0.2 µM, consistent with a previous study (Table 1Go; Barry et al. 2002). Interestingly, we found that peptide binding to Mg2+-CIB was also stoichiometric with a comparable affinity, suggesting that a similar interaction can occur in the presence of Mg2+. In each complex the emission wavelength maximum shifted only 2–4 nm to shorter wavelengths, indicating that although the Trp is held rigidly, it is not buried within a hydrophobic binding pocket. Fluorescence quenching studies also indicated that W988 is on the surface of each complex since the fluorescence emission was quenched ~70% as efficiently when bound to either Ca2+-CIB or Mg2+-CIB in comparison to the free peptide (Table 1Go). Experiments performed in the absence of salt gave very similar results to those in the presence of 100 mM KCl, suggesting that ionic interactions play a minor role in the binding of Ca2+-CIB or Mg2+-CIB to {alpha}IIb-L. All studies with {alpha}IIb-S also gave similar results to those with {alpha}IIb-L, although the emission wavelength maxima were shifted an additional ~2–4 nm toward shorter wavelengths, and binding to Mg2+-CIB was about fivefold weaker than with the full-length peptide (Table 1Go). The similar interactions with each peptide and lack of salt dependency suggest that both Ca2+-CIB and Mg2+-CIB bind to the membrane proximal region of {alpha}IIb predominantly through hydrophobic interactions.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 1. Interactions between CIB and {alpha}IIb peptides studied by fluorescence spectroscopy. (A) Steady state fluorescence emission spectra of free {alpha}IIb-L (——), and {alpha}IIb-L in the presence of 1.2 molar equivalents of Ca2+-CIB (- - - -), Mg2+-CIB (• • •), or apo-CIB (–• •–). Titrations of Ca2+-CIB (B), Mg2+-CIB (C), or apo-CIB (D) into {alpha}IIb-L in the absence (•) or presence ({blacksquare}) of 100 mM KCl or similar titrations into {alpha}IIb-S in the absence ({blacktriangledown}) or presence ({blacktriangleup}) of 100 mM KCl. The Kd was calculated from the best fit to the titration data (——), except for the titrations of apo-CIB into {alpha}IIb-S, which were not fit due to nonspecific interactions and are instead connected by dotted lines (• • •{blacktriangledown} • • •) and (• • •{blacktriangleup} • • •).

 

View this table:
[in this window]
[in a new window]
 
Table 1. Fluorescence parameters for {alpha}IIb-peptides binding to CIB
 
Similar studies using apo-CIB produced very different results than those obtained in the presence of Ca2+ or Mg2+. Most striking were a 22–24 nm blue shift for the fluorescence emission of both {alpha}IIb-L and {alpha}IIb-S when bound to apo-CIB and an almost complete lack of quenching by CsCl (Table 1Go). These results suggest that W988 is nearly completely buried within a hydrophobic pocket when bound to apo-CIB. In the presence of 100 mM KCl the changes in the fluorescence intensity also saturated near a stoichiometry of 1:1 and suggested that binding was of similar affinity to the interactions in the presence of Ca2+ or Mg2+. However, binding was approximately fivefold weaker in the absence of salt and an order of magnitude weaker in each case when the Kd was calculated from the change in emission wavelength maxima (Table 1Go). This suggests that peptide binding to apo-CIB is weaker than in the presence of Ca2+ or Mg2+. Titrations of {alpha}IIb-S with apo-CIB exhibited nonspecific binding of several peptides to a single apo-CIB molecule both in the presence and absence of salt, and therefore the Kd was not calculated (Fig. 1DGo). The reason for this nonspecific binding is likely because apo-CIB is a negatively charged, flexible molten globule with exposed nonpolar surfaces (Yamniuk et al. 2004) and {alpha}IIb-S is small and contains both nonpolar and basic regions. Because of this nonspecific binding we restricted our remaining studies to the interactions with {alpha}IIb-L, which encompasses the entire cytoplasmic domain of {alpha}IIb.

Isothermal titration calorimetry
Thermodynamic analysis of {alpha}IIb-L binding to CIB was performed by isothermal titration calorimetry (ITC). Under all conditions the binding was exothermic, and the data were best fit to a single site binding model (Fig. 2Go). The calorimetrically derived Kd values for {alpha}IIb-L binding to Ca2+-CIB or Mg2+-CIB were similar to each other and in the high nanomolar range, but slightly larger than the values calculated by fluorescence spectroscopy (Table 2Go). All thermodynamic parameters were similar in the absence of salt, confirming again that electrostatic interactions are not prevalent in either complex. The interactions were also thermodynamically distinct, with {alpha}IIb-L binding to Ca2+-CIB proceeding with small but favorable changes in both enthalpy and entropy, whereas binding to Mg2+-CIB was considerably more enthalpically favorable and entropically unfavorable (Table 2Go). Both {Delta}Hand T{Delta}S displayed strong linear but opposite temperature dependence known as enthalpy–entropy compensation (Fig. 3Go; Cornish-Bowden 2002). Therefore, the changes in {Delta}H and T{Delta}S offset to give similar binding free energy changes over the entire temperature range. The slope of the temperature dependence of {Delta}H was used to calculate the change in heat capacity ({Delta}Cp) for binding to each form of the protein. This in turn can be correlated to the change in solvent accessible nonpolar surface area accompanying peptide binding (Loladze et al. 2001). Importantly, the {Delta}Cp for {alpha}IIb-L binding to Ca2+-CIB (–1.1 kJ/mol K) and Mg2+-CIB (–1.3 kJ/mol K) were each negative and of similar magnitude, indicating that the amount of nonpolar surface buried upon formation of each complex is comparable. In the presence of saturating concentrations of both Ca2+ and Mg2+, the thermodynamics of binding were similar to Ca2+ alone, consistent with the higher affinity of CIB for Ca2+ over Mg2+ (Yamniuk et al. 2004).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. Representative isothermal titration calorimetry experiments for {alpha}IIb-L binding to Ca2+-CIB (A), Mg2+-CIB (B), and apo-CIB (C) in 20 mM HEPES, 100 mM KCl (pH 7.3) at 37°C. The top panels display the baseline corrected calorimetric titration data while the bottom panels display the derived binding isotherms for each experiment.

 

View this table:
[in this window]
[in a new window]
 
Table 2. Thermodynamics of {alpha}IIb-L binding to CIB as determined by isothermal titration calorimetry in 20 mM HEPES, 100 mM KCl (pH 7.3)
 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 3. Temperature dependence of the enthalpy (solid symbols) or entropy (open symbols) of {alpha}IIb-L binding to CIB in the presence of 2 mM Ca2+ (circles), 4 mM Mg2+ (squares), or 2 mM Ca2+ and 4 mM Mg2+ (triangles). The linear regression is shown as solid, dotted, and dashed lines, respectively.

 
The binding of {alpha}IIb-L to apo-CIB was also exothermic, as seen in Figure 2CGo. However, the stoichiometry was less than 1, and the binding was weaker than in the presence of Ca2+ or Mg2+ (Table 2Go). The calorimetric heat change also displayed a slow return to the baseline that required increased time between injections, which is a characteristic of nonspecific interactions. Due to the weaker binding and more noisy enthalpy data, the estimated thermodynamic parameters for apo-CIB binding to {alpha}IIb-L are less reliable than those obtained for Ca2+-CIB or Mg2+-CIB.

NMR spectroscopy
To investigate the extent of peptide-induced conformational changes in CIB, we recorded heteronuclear 1H, 15N-HSQC NMR spectra of uniformly 15N-labeled Ca2+-CIB, Mg2+-CIB, and apo-CIB, in the presence and absence of unlabeled {alpha}IIb-L. These spectra are essentially the fingerprint for the protein where each peak represents a backbone or side chain amide group. As has been discussed in more detail previously (Yamniuk et al. 2004), the spectra of Ca2+-CIB and Mg2+-CIB are characteristic of folded proteins, where the downfield Gly121 and Gly166 peaks represent Ca2+ orMg2+ coordination at EF-III or EF-IV, respectively (Fig. 4A,BGo). Less than the expected number of peaks are observed in each spectrum, presumably due to chemical exchange broadening from weak self-association or flexible internal regions. There are also more distinct backbone amide peaks detected for Ca2+-CIB (~160) than Mg2+-CIB (~140) in the absence of peptide, consistent with greater structural stability in the presence of Ca2+ than Mg2+. The binding of {alpha}IIb-L induces chemical shift changes for most of the peaks in both the Ca2+-CIB and Mg2+-CIB spectra, indicative of large peptide-induced conformational changes in each form of the protein. Interestingly ~160 distinct backbone amide peaks are now observed in the spectra of each complex, indicating that peptide binding stabilizes the structure of some previously exchange-broadened regions of Mg2+-CIB. This includes a peak for G166 of Mg2+-CIB that was not observed in the absence of {alpha}IIb-L, suggesting that the structure of EF-IV of Mg2+-CIB is stabilized in the complex, possibly by Mg2+ binding directly to this site. Also noteworthy is that many of the peaks in each complex have similar chemical shifts, indicating that regions of the protein adopt similar structures when bound to {alpha}IIb-L in the presence of Ca2+ or Mg2+ (Fig. 4DGo). However these spectra are not identical, indicating that Ca2+ binding to the Mg2+-CIB-{alpha}IIb-L complex does induce some small conformational changes.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 4. 1H, 15N HSQC NMR spectra of uniformly 15N-labeled Ca2+-CIB (A), Mg2+-CIB (B), and apo-CIB (C) in the presence and absence of unlabeled {alpha}IIb-L at 37°C. (D) Overlaid spectra of the Ca2+-CIB-{alpha}IIb-L and Mg2+-CIB-{alpha}IIb-L complexes. G121 and G166 represent Gly6 of the Ca2+-binding loop from EF-III and EF-IV, respectively, as determined previously (Yamniuk et al. 2004). Note that the G166 peaks for Ca2+-CIB in the presence and absence of {alpha}IIb-L overlap in A, whereas G166 of Mg2+-CIB is only observed in the presence of {alpha}IIb-L in B.

 
The spectrum of apo-CIB exhibits severe chemical exchange broadening and chemical shift degeneracy characteristic of a molten globule (Fig. 4CGo). In the presence of {alpha}IIb-L an increase in chemical exchange was observed consistent with a weak interaction, and also showing that peptide binding does not stabilize the structure of apo-CIB. Attempts to improve the apo-CIB NMR spectra by varying protein concentration, temperature, pH, salt, or adding various detergents have been unsuccessful, indicating that the structural instability of apo-CIB is intrinsic to the protein and not dependent on experimental conditions.


    Discussion
 TOP
 Abstract
 Introduction
 Results
 Discussion
 Materials and methods
 References
 
Previous studies have shown that CIB is capable of binding to the {alpha}IIb cytoplasmic domain in the absence of divalent metal ions, and that its affinity increases in the presence of Ca2+ (Shock et al. 1999;Vallar et al. 1999;Barry et al. 2002; Tsuboi 2002). Our structural studies have demonstrated that apo-CIB is a molten globule, but adopts a folded structure in the presence of Ca2+ or Mg2+ (Yamniuk et al. 2004). Here we demonstrate that both Ca2+-CIB and Mg2+-CIB bind to {alpha}IIb peptides with high affinity and by a similar binding mode, but that binding to apo-CIB is of lower affinity and involves a different mechanism. The apo-CIB binding mechanism might involve some nonspecific interactions between the exposed hydrophobic surfaces of apo-CIB and the nonpolar residues of {alpha}IIb, including W988, as evidenced by the slow ITC baseline recovery and binding of several {alpha}IIb-S peptides observed by fluorescence spectroscopy. However, the interaction with apo-CIB is unlikely to be of biological importance since CIB would never exist in vivo devoid of divalent metal ions due to the high intracellular Mg2+ concentration. Instead, Mg2+-CIB would be the major intracellular form of the protein, with Ca2+ potentially displacing Mg2+ upon intracellular Ca2+ influx in a stimulated cell.

Both fluorescence spectroscopy and ITC demonstrate that the similar mode of {alpha} IIb-binding to Ca2+-CIB and Mg2+-CIB involves predominantly hydrophobic interactions with little contribution from electrostatic interactions. Studies using mutant {alpha}IIb peptides have indicated that L983, W988, F992, and F993 of {alpha}IIb are particularly important in binding, and that this region of {alpha}IIb likely interacts with the C domain of CIB (Barry et al. 2002). We also found that W988 of {alpha}IIb-L is on the surface of the complex with either Ca2+-CIB or Mg2+-CIB, similar to W352 of CnA bound to CnB, but unlike many CaM-binding peptides where the Trp is completely shielded from solvent by the protein (Crivici and Ikura 1995; Ke and Huai 2003; Yamniuk and Vogel 2004). This supports the previous proposal that the CIB-{alpha}IIb interaction is similar to the CnB–CnA interaction (Barry et al. 2002). Peptide binding to Ca2+-CIB or Mg2+-CIB is also accompanied by comparable changes in heat capacity, indicating that the nonpolar binding interface is similar in the complexes with Ca2+-CIB or Mg2+-CIB. However, the {Delta}Cp of {alpha}IIb-L binding to CIB was considerably less than that associated with peptides binding to other EF-hand Ca2+-regulatory proteins such as CaM (Wintrode and Privalov 1997; Brokx et al. 2001) and S100P (Gribenko et al. 2002), suggesting that the hydrophobic binding surface of CIB is somewhat smaller than these proteins. In fact the {Delta}Cp associated with the CIB-{alpha}IIb-L interaction (~–1.2 kJ/mol K) is quite similar to that associated with peptides binding to a single domain of CaM (~–1.6 kJ/mol K) (Brokx et al. 2001), suggesting that {alpha}IIb-L binds to only one domain of CIB, possibly the C domain as suggested by Parise and coworkers (Barry et al. 2002).

The high affinity interaction between CIB and {alpha}IIb in the presence of Mg2+ indicates that CIB should be capable of binding to the integrin in vivo independent of a Ca2+ stimulus. This feature distinguishes CIB from many related Ca2+-regulatory proteins that show strict Ca2+-dependent target protein binding (Ikura 1996; Bhattacharya et al. 2004). However, the majority of evidence suggests that CIB binds only to activated {alpha}IIb{beta}3, indicating that it does not remain constitutively bound in vivo (Vallar et al. 1999; Naik and Naik 2003). Therefore, other mechanisms must regulate the interaction between CIB and {alpha}IIb in vivo. For example, the membrane proximal CIB-binding region of {alpha}IIb also interacts with the {beta}3 cytoplasmic domain, and it is this interaction that is believed to maintain {alpha}IIb{beta}3 in an inactive conformation (Hughes et al. 1995, 1996; Vinogradova et al. 2002; Weljie et al. 2002). This association between the {alpha}IIb and {beta}3 cytoplasmic domains could prevent the binding of CIB in vivo. Alternatively, CIB binding could be regulated by other accessory proteins that associate with either the {alpha}IIb or {beta}3 domains. The protein phosphatase PP1 was recently shown to interact with the 989KVGF992 region of {alpha}IIb, but to dissociate upon {alpha}IIb{beta}3 binding to fibrinogen (Vijayan et al. 2004). Likewise the ion channel-forming protein ICln has been shown to influence the activity of {alpha}IIb{beta}3 through a high affinity interaction with the 989KVGFFKR995 region of {alpha}IIb (Larkin et al. 2004). Since these binding regions also overlap with the CIB-binding domain, dissociation of PP1 or ICln might be a prerequisite to CIB binding. Other proteins such as the {beta}3 binding protein Talin might also be required to disrupt the {alpha}IIb–{beta}3 interaction (Vinogradova et al. 2002; Garcia-Alvarez et al. 2003; Tadokoro et al. 2003), which could free {alpha}IIb for a subsequent binding to CIB. Moreover, CIB contains several consensus phosphorylation sequences (Naik et al. 1997) that might require dephosphorylation prior to {alpha}IIb-binding, while phosphorylation of Tyr and Thr residues of the {beta}3 integrin tail has also been demonstrated (Jenkins et al. 1998; Lerea et al. 1999; Kirk et al. 2000) and this in turn could also fine-tune its interactions with the {alpha}IIb domain.

Although CIB is capable of binding to {alpha}IIb in the absence of Ca2+, subtle Ca2+-induced conformational changes in CIB could be important for regulating the activity of {alpha}IIb{beta}3. Indeed although the NMR spectra of Ca2+-CIB or Mg2+-CIB bound to {alpha}IIb-L were similar, they were not identical. This type of mechanism takes place in the troponin complex in vertebrate skeletal muscle where the Mg2+-bound C domain of troponin C (TnC) constitutively tethers the protein to troponin I (TnI), awaiting subtle Ca2+-induced conformational changes that activate the complex (Zot and Potter 1982; Finley et al. 2000). Notably, Mg2+ binds to EF-III but not EF-IV of TnC in the absence of TnI, but to both EF-III and EF-IV in the presence of TnI (Finley et al. 2000). Moreover the {Delta}Cp associated with Ca2+-TnC or Mg2+-TnC binding to TnI are nearly identical (Calvert et al. 2000). These characteristics were also observed with CIB. Although N-terminal myristoylation of CIB is not required for binding to {alpha}IIb, a Ca2+-induced myristoyl switch mechanism similar to the NCS proteins (Ames and Ikura 2002; O’Callaghan and Burgoyne 2003) could also target CIB toward the cytoplasmic membrane, which would increase the probability of an interaction with {alpha}IIb. Therefore, although the Mg2+-dependent binding of CIB to {alpha}IIb canoccur in the absence of Ca2+, Ca2+-binding to CIB could potentially alter its interactions with {alpha}IIb{beta}3 and contribute to the regulation of integrin-mediated signaling events.


    Materials and methods
 TOP
 Abstract
 Introduction
 Results
 Discussion
 Materials and methods
 References
 
Protein expression, purification, and peptide synthesis
Unlabeled and uniformly 15N-labeled CIB were expressed and purified as previously described (Yamniuk et al. 2004). Both peptides used in this study were synthesized commercially and were determined to be more than 95% pure by high pressure liquid chromatography and matrix-assisted laser desorption/ionization mass spectroscopy. Peptide {alpha}IIb-L (Ac-LVLAMWKVGFFKRNRPPLEEDDEEGQ-OH) corresponds to amino acids 983–1008 of the {alpha}IIb subunit of platelet integrin {alpha}IIb{beta}3, and comprises the entire cytoplasmic domain. This peptide contains the E1008Q post-translational modification that was suggested by mass spectrometry (Calvete et al. 1990). Peptide {alpha}IIb-S (Ac-LVLAMWKVGFFKRNR-NH2) is a shortened version of {alpha}IIb-L containing only the membrane proximal region of {alpha}IIb.

Fluorescence spectroscopy
All fluorescence spectra were recorded on a Varian Cary Eclipse spectrofluorimeter. In each experiment the Trp residue of {alpha}IIb-L or {alpha}IIb-S was selectively excited at 295 nm using an excitation slit width of 5 nm, and emission spectra were recorded from 300 to 450 nm using an emission slit width of 10 nm. All samples consisted of 8–10 µM peptide in 20 mM HEPES, 1 mM DTT (pH 7.3) with or without 100 mM KCl. Studies with Ca2+-CIB were performed in 2 mM CaCl2, while Mg2+-CIB samples contained 2 mM MgCl2 and 0.5 mM EGTA, and apo-CIB samples contained 2 mM EDTA and 2 mM EGTA. This strategy for producing Ca2+-, Mg2+-, and apo-CIB has been described previously (Yamniuk et al. 2004). Titration experiments involved sequential addition of microliter volumes of 100–200 µM CIB in the respective buffer into 1-ml samples of {alpha}IIb-L or {alpha}IIb-S. The changes in fluorescence intensity at the emission wavelength maxima of each complex were used to calculate the Kd for the interaction. In the case of {alpha}IIb-L binding to apo-CIB, a second estimate for the Kd was obtained using the wavelength change of this emission maximum ({Delta}{lambda}max). For fluorescence quenching experiments, 1-ml samples of 10 µM peptide saturated with 12 µM CIB were titrated with aliquots from a 5 M solution of CsCl to a final concentration of 1.4 M, and the fluorescence emission intensity was recorded at 351 nm for Ca2+-CIB and Mg2+-CIB, 333 nm for apo-CIB, and 355 nm for the unbound peptides. A total of six titration points were used in each case to generate Stern-Volmer plots that follow Equation 1:


(1)

where Q is the quencher CsCl, Io is the fluorescence intensity at 0 M CsCl, I is the intensity at each titration point, and Ksv is the quenching constant. All Stern-Volmer plots were linear and there were no changes in the emission wavelength maxima during the CsCl titrations, indicating that no significant structural changes occurred in the presence of large amounts of CsCl.

Isothermal titration calorimetry
All ITC experiments were performed on a MicroCal VP-ITC microcalorimeter. CIB was dissolved in 20 mM HEPES, 100 mM KCl (pH 7.3) and 2–10 mM DTT, and incubated at room temperature for several hours to reduce all sulfhydryl groups. Since the presence of DTT causes undesirable noise in ITC baselines, it was removed prior to ITC analysis by passing the samples through an Econo-Pac 10DG column (BioRad) equilibrated with 20 mM HEPES, 100 mM KCl (pH 7.3). Then concentrated metal ion or chelator solutions were added to give final concentrations of 2 mM CaCl2 for Ca2+- CIB, 4 mM MgCl2 and 1 mM EGTA for Mg2+-CIB, 2 mM CaCl2 and 4 mM MgCl2 for Ca2+(Mg2+)-CIB, or 2 mM EDTA and 2 mM EGTA for apo-CIB. The {alpha}IIb-L peptide was simply dissolved in the respective ITC buffer. Titrations consisted of 4–11-µL injections of 280–500 µM CIB into a 1.43-mL sample cell containing 15–25 µM {alpha}IIb-L at various temperatures. The heat of dilution was estimated from the heat of injection after saturation and subtracted before performing the curve fitting (Pierce et al. 1999). The stoichiometry (N), association constant (Ka), and enthalpy change ({Delta}H) were each obtained directly from the data, while the entropy change ({Delta}S) and Gibbs free energy change ({Delta}G) were calculated using Equations 2 and 3:


(2)


(3)

By performing the titrations at multiple temperatures, the change in heat capacity associated with binding was also calculated using Equation 4:


(4)

All data were fit to a one-site model using MicroCal Origin software.

NMR spectroscopy
All 1H, 15N HSQC NMR spectra were recorded at 37°C on a Bruker Avance 500 NMR spectrometer equipped with a triple resonance inverse cryoprobe with a single axis Z-gradient. Samples of 570 µM CIB in 20 mM HEPES, 100 mM KCl, 10 mM d10-DTT, 10% D2O (pH 7.5±0.1) with an additional 3 mM CaCl2 for Ca2+-CIB, 5 mM MgCl2+1 mM EGTA for Mg2+-CIB, or 2.5 mM EDTA+2.5 mM EGTA for apo-CIB, were titrated with 1.1–1.2 mM {alpha}IIb-L in the respective buffer. Each spectrum was recorded with sweep widths of 8012.82 Hz and 1600.0 Hz and carrier frequencies of 500.13235 MHz and 50.68365 MHz for the 1H and 15N dimensions, respectively. Quadrature detection in the F1 dimension was obtained using the echo/anti-echo time-proportional phase increment method. A total of 2048x256 real data points were recorded in 1H and 15N, respectively, with 16 scans for peptide-free CIB and 48 scans for peptide-bound CIB in order to obtain a similar signal-to-noise ratio with the peptide-diluted samples. Each spectrum was zero filled once in each dimension and referenced in 1H to 0 ppm using the DSS signal in the one-dimensional 1H spectrum of each sample and in 15N using the conversion factor of 0.101329118 as suggested by Sykes and coworkers (Wishart et al. 1995). Data analysis was performed using NMRpipe and NMRDraw software (Delaglio et al. 1995).


    Acknowledgments
 
This research is supported by the Canadian Institutes of Health Research (CIHR). H.J.V. holds a senior scientist award from the Alberta Heritage Foundation for Medical Research (AHFMR), while A.P.Y. is a recipient of AHFMR and Natural Sciences and Engineering Research Council of Canada (NSERC) studentship awards. The isothermal titration microcalorimeter was purchased through a grant from the Alberta Science and Research Authority (ASRA) to the Alberta Network of Proteomics Innovation. The Bio-NMR center at the University of Calgary is maintained through funds provided by the CIHR and the University of Calgary. We wish to thank Dr. D.D. McIntyre for the continuous upkeep of the NMR instrumentation and Dr. Tomohiko Murase for his expertise in fluorescence data analysis.


    References
 TOP
 Abstract
 Introduction
 Results
 Discussion
 Materials and methods
 References
 
Ames, J.B. and Ikura, M. 2002. Structure and membrane-targeting mechanism of retinal Ca2+-binding proteins, recoverin and GCAP-2. Adv. Exp. Med. Biol. 514: 333–348.[Medline]

Barry, W.T., Boudignon-Proudhon, C., Shock, D.D., McFadden, A., Weiss, J.M., Sondek, J., and Parise, L.V. 2002. Molecular basis of CIB binding to the integrin {alpha} IIb cytoplasmic domain. J. Biol. Chem. 277: 28877–28883.[Abstract/Free Full Text]

Bhattacharya, S., Bunick, C.G., and Chazin, W.J. 2004. Target selectivity in EF-hand calcium binding proteins. Biochim. Biophys. Acta 1742: 69–79.[Medline]

Brokx, R.D., Lopez, M.M., Vogel, H.J., and Makhatadze, G.I. 2001. Energetics of target peptide binding by calmodulin reveals different modes of binding. J. Biol. Chem. 276: 14083–14091.[Abstract/Free Full Text]

Calvert, M.J., Ward, D.G., Trayer, H.R., and Trayer, I.P. 2000. The importance of the carboxyl-terminal domain of cardiac troponin C in Ca2+-sensitive muscle regulation. J. Biol. Chem. 275: 32508–32515.[Abstract/Free Full Text]

Calvete, J.J. 2004. Structures of integrin domains and concerted conformational changes in the bidirectional signaling mechanism of {alpha}IIb{beta}3. Exp. Biol. Med. (Maywood) 229: 732–744.[Abstract/Free Full Text]

Calvete, J.J., Schafer, W., Henschen, A., and Gonzalez-Rodriquez, J. 1990. C-terminal amino acid determination of the transmembrane subunits of the human platelet fibrinogen receptor, the GPIIb/IIIa complex. FEBS Lett. 263: 43–46.[CrossRef][Medline]

Cornish-Bowden, A. 2002. Enthalpy-entropy compensation: A phantom phenomenon. J. Biosci. 27: 121–126.[Medline]

Crivici, A. and Ikura, M. 1995. Molecular and structural basis of target recognition by calmodulin. Annu. Rev. Biophys. Biomol. Struct. 24: 85–116.[CrossRef][Medline]

Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6: 277–293.[Medline]

Fang, X., Chen, C., Wang, Q., Gu, J., and Chi, C. 2001. The interaction of the calcium- and integrin-binding protein (CIBP) with the coagulation factor VIII. Thromb. Res. 102: 177–185.[CrossRef][Medline]

Finley, N., Dvoretsky, A., and Rosevear, P.R. 2000. Magnesium-calcium exchange in cardiac troponin C bound to cardiac troponin I. J. Mol. Cell. Cardiol. 32: 1439–1446.[CrossRef][Medline]

Garcia-Alvarez, B., de Pereda, J.M., Calderwood, D.A., Ulmer, T.S., Critchley, D., Campbell, I.D., Ginsberg, M.H., and Liddington, R.C. 2003. Structural determinants of integrin recognition by talin. Mol. Cell 11: 49–58.[CrossRef][Medline]

Gribenko, A.V., Guzman-Casado, M., Lopez, M.M., and Makhatadze, G.I. 2002. Conformational and thermodynamic properties of peptide binding to the human S100P protein. Protein Sci. 11: 1367–1375.[Abstract/Free Full Text]

Haataja, L., Kaartinen, V., Groffen, J., and Heisterkamp, N. 2002. The small GTPase Rac3 interacts with the integrin-binding protein CIB and promotes integrin {alpha}(IIb){beta}(3)-mediated adhesion and spreading. J. Biol. Chem. 277: 8321–8328.[Abstract/Free Full Text]

Henderson, M.J., Russell, A.J., Hird, S., Munoz, M., Clancy, J.L., Lehrbach, G.M., Calanni, S.T., Jans, D.A., Sutherland, R.L., and Watts, C.K. 2002. EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response. J. Biol. Chem. 277: 26468–26478.[Abstract/Free Full Text]

Hollenbach, A.D., McPherson, C.J., Lagutina, I., and Grosveld, G. 2002. The EF-hand calcium-binding protein calmyrin inhibits the transcriptional and DNA-binding activity of Pax3. Biochim. Biophys. Acta 1574: 321–328.[Medline]

Hughes, P.E., O’Toole, T.E., Ylanne, J., Shattil, S.J., and Ginsberg, M.H. 1995. The conserved membrane-proximal region of an integrin cytoplasmic domain specifies ligand binding affinity. J. Biol. Chem. 270: 12411–12417.[Abstract/Free Full Text]

Hughes, P.E., Diaz-Gonzalez, F., Leong, L., Wu, C., McDonald, J.A., Shattil, S.J., and Ginsberg, M.H. 1996. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J. Biol. Chem. 271: 6571–6574.[Abstract/Free Full Text]

Hwang, P.M. and Vogel, H.J. 2000. Structures of the platelet calcium- and integrin-binding protein and the {alpha}IIb-integrin cytoplasmic domain suggest a mechanism for calcium-regulated recognition; homology modelling and NMR studies. J. Mol. Recognit. 13: 83–92.[CrossRef][Medline]

Ikura, M. 1996. Calcium binding and conformational response in EF-hand proteins. Trends Biochem. Sci. 21: 14–17.[CrossRef][Medline]

Ito, A., Uehara, T., and Nomura, Y. 2000. Isolation of Ich-1S (caspase-2S)- binding protein that partially inhibits caspase activity. FEBS Lett. 470: 360–364.[CrossRef][Medline]

Jenkins, A.L., Nannizzi-Alaimo, L., Silver, D., Sellers, J.R., Ginsberg, M.H., Law, D.A., and Phillips, D.R. 1998. Tyrosine phosphorylation of the {beta}3 cytoplasmic domain mediates integrin–cytoskeletal interactions. J. Biol. Chem. 273: 13878–13885.[Abstract/Free Full Text]

Kauselmann, G., Weiler, M., Wulff, P., Jessberger, S., Konietzko, U., Scafidi, J., Staubli, U., Bereiter-Hahn, J., Strebhardt, K., and Kuhl, D. 1999. The polo-like protein kinases Fnk and Snk associate with a Ca(2+)- and integrin-binding protein and are regulated dynamically with synaptic plasticity. EMBO J. 18: 5528–5539.[CrossRef][Medline]

Ke, H. and Huai, Q. 2003. Structures of calcineurin and its complexes with immunophilins-immunosuppressants. Biochem. Biophys. Res. Commun. 311: 1095–1102.[CrossRef][Medline]

Kirk, R.I., Sanderson, M.R., and Lerea, K.M. 2000. Threonine phosphorylation of the {beta}3 integrin cytoplasmic tail, at a site recognized by PDK1 and Akt/PKB in vitro, regulates Shc binding. J. Biol. Chem. 275: 30901–30906.[Abstract/Free Full Text]

Larkin, D., Murphy, D., Reilly, D.F., Cahill, M., Sattler, E., Harriott, P., Cahill, D.J., and Moran, N. 2004. ICln, a novel integrin {alpha}IIb{beta}3-associated protein, functionally regulates platelet activation. J. Biol. Chem. 279: 27286–27293.[Abstract/Free Full Text]

Lerea, K.M., Cordero, K.P., Sakariassen, K.S., Kirk, R.I., and Fried, V.A. 1999. Phosphorylation sites in the integrin {beta}3 cytoplasmic domain in intact platelets. J. Biol. Chem. 274: 1914–1919.[Abstract/Free Full Text]

Loladze, V.V., Ermolenko, D.N., and Makhatadze, G.I. 2001. Heat capacity changes upon burial of polar and nonpolar groups in proteins. Protein Sci. 10: 1343–1352.[Abstract/Free Full Text]

Matsuno, K., Koyama, M., Takeda, H., Abe, K., Sakurada, K., Miyazaki, T., and Kobayashi, K. 1993. Cytosolic free magnesium concentration in human platelets. Thromb. Res. 69: 131–137.[CrossRef][Medline]

Mould, A.P. and Humphries, M.J. 2004. Regulation of integrin function through conformational complexity: Not simply a knee-jerk reaction? Curr. Opin. Cell. Biol. 16: 544–551.[CrossRef][Medline]

Naik, U.P. and Naik, M.U. 2003. Association of CIB with GPIIb/IIIa during outside-in signaling is required for platelet spreading on fibrinogen. Blood 102: 1355–1362.[Abstract/Free Full Text]

Naik, U.P., Patel, P.M., and Parise, L.V. 1997. Identification of a novel calcium-binding protein that interacts with the integrin {alpha}IIb cytoplasmic domain. J. Biol. Chem. 272: 4651–4654.[Abstract/Free Full Text]

O’Callaghan, D.W. and Burgoyne, R.D. 2003. Role of myristoylation in the intracellular targeting of neuronal calcium sensor (NCS) proteins. Biochem. Soc. Trans. 31: 963–965.[Medline]

Pierce, M.M., Raman, C.S., and Nall, B.T. 1999. Isothermal titration calorimetry of protein–protein interactions. Methods 19: 213–221.[CrossRef][Medline]

Shock, D.D., Naik, U.P., Brittain, J.E., Alahari, S.K., Sondek, J., and Parise, L.V. 1999. Calcium-dependent properties of CIB binding to the integrin {alpha}IIb cytoplasmic domain and translocation to the platelet cytoskeleton. Biochem. J. 342: 729–735.

Stabler, S.M., Ostrowski, L.L., Janicki, S.M., and Monteiro, M.J. 1999. A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer’s disease presenilin 2 protein. J. Cell. Biol. 145: 1277–1292.[Abstract/Free Full Text]

Tadokoro, S., Shattil, S.J., Eto, K., Tai, V., Liddington, R.C., de Pereda, J.M., Ginsberg, M.H., and Calderwood, D.A. 2003. Talin binding to integrin {beta} tails: A final common step in integrin activation. Science 302: 103–106.[Abstract/Free Full Text]

Tsuboi, S. 2002. Calcium integrin-binding protein activates platelet integrin {alpha} IIb{beta}3. J. Biol. Chem. 277: 1919–1923.[Abstract/Free Full Text]

Vallar, L., Melchior, C., Plancon, S., Drobecq, H., Lippens, G., Regnault, V., and Kieffer, N. 1999. Divalent cations differentially regulate integrin {alpha}IIb cytoplasmic tail binding to {beta}3 and to calcium- and integrin-binding protein. J. Biol. Chem. 274: 17257–17266.[Abstract/Free Full Text]

Vijayan, K.V., Liu, Y., Li, T.T., and Bray, P.F. 2004. Protein phosphatase 1 associates with the integrin {alpha}IIb subunit and regulates signaling. J. Biol. Chem. 279: 33039–33042.[Abstract/Free Full Text]

Vinogradova, O., Velyvis, A., Velyviene, A., Hu, B., Haas, T., Plow, E., and Qin, J. 2002. A structural mechanism of integrin {alpha}(IIb){beta}(3) "inside-out" activation as regulated by its cytoplasmic face. Cell 110: 587–597.[CrossRef][Medline]

Weljie, A.M., Hwang, P.M., and Vogel, H.J. 2002. Solution structures of the cytoplasmic tail complex from platelet integrin {alpha} IIb- and {beta} 3-subunits. Proc. Natl. Acad. Sci. 99: 5878–5883.[Abstract/Free Full Text]

Whitehouse, C., Chambers, J., Howe, K., Cobourne, M., Sharpe, P., and Solomon, E. 2002. NBR1 interacts with fasciculation and elongation protein {zeta}-1 (FEZ1) and calcium and integrin binding protein (CIB) and shows developmentally restricted expression in the neural tube. Eur. J. Biochem. 269: 538–545.[Medline]

Wintrode, P.L. and Privalov, P.L. 1997. Energetics of target peptide recognition by calmodulin: A calorimetric study. J. Mol. Biol. 266: 1050–1062.[CrossRef][Medline]

Wishart, D.S., Bigam, C.G., Yao, J., Abildgaard, F., Dyson, H.J., Oldfield, E., Markley, J.L., and Sykes, B.D. 1995. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR 6: 135–140.[Medline]

Wu, X. and Lieber, M.R. 1997. Interaction between DNA-dependent protein kinase and a novel protein, KIP. Mutat. Res. 385: 13–20.[Medline]

Xiao, T., Takagi, J., Coller, B.S., Wang, J.H., and Springer, T.A. 2004. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432: 59–67.[CrossRef][Medline]

Yamniuk, A.P. and Vogel, H.J. 2004. Calmodulin’s flexibility allows for promiscuity in its interactions with target proteins and peptides. Mol. Biotechnol. 27: 33–57.[CrossRef][Medline]

Yamniuk, A.P., Nguyen, L.T., Hoang, T.T., and Vogel, H.J. 2004. Metal ion binding properties and conformational states of calcium- and integrin-binding protein. Biochemistry 43: 2558–2568.[CrossRef][Medline]

Zot, H.G. and Potter, J.D. 1982. A structural role for the Ca2+-Mg2+ sites on troponin C in the regulation of muscle contraction. Preparation and properties of troponin C depleted myofibrils. J. Biol. Chem. 257: 7678–7683.[Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. P. Yamniuk, H. Ishida, and H. J. Vogel
The Interaction between Calcium- and Integrin-binding Protein 1 and the {alpha}IIb Integrin Cytoplasmic Domain Involves a Novel C-terminal Displacement Mechanism
J. Biol. Chem., September 8, 2006; 281(36): 26455 - 26464.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.041312805v1
14/6/1429    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamniuk, A. P.
Right arrow Articles by Vogel, H. J.